Drug firm Ajanta Pharma on Wednesday Nov 02,2016 said it has launched in the US market tablets used for lowering blood pressure.
After the approval of the United States Food and Drug Administration (USFDA), the company has launched Amlodipine Olmesartan Medoxomil tablets in the US market through its arm Ajanta Pharma USA Inc," the company said in a BSE filing on Wednesday Nov 02,2016
The company's product is a generic version of Daiichi Sankyo Inc's Azor tablets, it added.
The product has been launched in four strengths 5mg20mg, 5mg40mg, 10mg20mg and 10mg40mg, Ajanta Pharma said.
"Amlodipine Olmesartan Medoxomil tablets is part of an ever growing portfolio of products that Ajanta has developed for the US market," it added.
No comments:
Post a Comment